Navigation Links
Global Med Technologies(R) Licenses 90th Site in the Southeastern U.S.
Date:3/31/2009

lutions to hospitals and donor centers.

Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.

For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.

This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.


'/>"/>
SOURCE Global Med Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. NovaBay and Galderma Enter Into Global Agreement to Develop and Commercialize NovaBays Novel Aganocide Drugs for Major Dermatological Conditions
2. Forward-Thinking Patient Recruitment Company Poised to Create Bridges Between Japanese Clinical R&D Industry and Global Clinical Trial Marketplace
3. 3rd Global Jatrophaworld Training 2009... Set to Create and Build a Sustainable non-food Biodiesel Industry
4. PAREXEL Expert to Address Value of Incorporating Asia Into Global Clinical Development at BioMedical Asia 2009
5. Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry
6. Schering-Plough to Webcast Presentation at Barclays Capital Global Healthcare Conference
7. BioMed Realty Trust to Present at Citi 2009 Global Property CEO Conference
8. News Release: Homeland Security to Take Centre Stage with Global Security Asia 2009
9. Abbott to Present at Barclays Global Healthcare Conference
10. Frost & Sullivan Forecasts Early Rebound: Strong Growth Ahead for Global Economy
11. Global Biopharmaceutical Leader in Peptide Research Expands Commitment in San Diego/U.S. With New R&D Facility and Ready-To-Market Prostate Cancer Treatment Degarelix
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... and commercialization of a once-daily, oral therapy for the ... financial results for the period ended June 30, 2014. ... Reported cash and cash equivalents totaling $37.4 million on ... 2013.  , Reported a net loss of $3.9 ...
(Date:7/24/2014)... 24, 2014 -- Keryx Biopharmaceuticals, Inc. (Nasdaq:KERX) (the "Company") ... active control Phase 3 study of Zerenex (ferric citrate), ... the treatment of hyperphosphatemia in patients with end-stage renal ... and iRon delivery with FErric CiTrate in EsrD) was ... American Society of Nephrology ( JASN ). ...
(Date:7/24/2014)... Calif. , July 24, 2014  Asterias ... in the emerging field of regenerative medicine, announced ... of a presentation to investors on Tuesday, July ... PDT.  The presentation will include an overview of ... access the webcast, visit http://www.ustream.tv/channel/asterias-biotherapeutics at ...
(Date:7/24/2014)... Yet, scientists are making progress in devising suitable ... approach relies on quantum dotsa kind of artificial ... A new study demonstrates that changing the coupling ... electrical impulses can help better control them. This ... as quantum information units, which would produce faster ...
Breaking Biology Technology:Galmed Pharmaceuticals Reports First Half 2014 Financial Results 2Galmed Pharmaceuticals Reports First Half 2014 Financial Results 3Galmed Pharmaceuticals Reports First Half 2014 Financial Results 4Galmed Pharmaceuticals Reports First Half 2014 Financial Results 5Galmed Pharmaceuticals Reports First Half 2014 Financial Results 6Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 2Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 3Zerenex (ferric citrate) long-term Phase 3 study results published in JASN 4Asterias Biotherapeutics Announces Live Investor Webcast 2Asterias Biotherapeutics Announces Live Investor Webcast 3Asterias Biotherapeutics Announces Live Investor Webcast 4
... Cycle built a significant presence in the bicycle industry ... on the market. But the Madison, Wis.-based company has ... of radio frequency identification (RFID) technology into its systems. ... Schwinn, Murray and Roadmaster along with newer names such ...
... women entrepreneurs? , ,The market is good for their ... and the revenue from them has increased faster than the ... less likely to fail, too, experts say. , ,Finding money ... , ,The problem is not limited to Wisconsin, but is ...
... Neurognostics, Inc ., a Wisconsin company specializing ... announced today that the Food and Drug Administration (FDA) ... its trademarked MindState fDAD. MindState fDAD had previously ... acquisition device. The Special 510(k) allows Neurognostics to enhance ...
Cached Biology Technology:Pacific Cycle rides full speed into RFID 2Pacific Cycle rides full speed into RFID 3Women and Capital: Two words that dont always marry 2Women and Capital: Two words that dont always marry 3Women and Capital: Two words that dont always marry 4
(Date:7/24/2014)... sticky research out of York University shows a surprisingly ... toxic grass fungus: moose saliva (yes moose saliva). ... "Ungulate saliva inhibits a grassendophyte mutualism" shows that moose ... (which hosts a fungus called epichlo festucae that produces ... less toxicity. , "Plants have evolved defense mechanisms to ...
(Date:7/24/2014)... researchers has developed a new nanoscale agent for imaging ... assessing the function and properties of the GI tract ... treatment of gut diseases. , Illnesses such ... inflammatory bowel disease all occur in the intestine and ... diseases such as diabetes and Parkinson,s. , Until ...
(Date:7/24/2014)... at The University of Texas Health Science Center at ... to help Harris County residents whose vision problems cannot ... with corrective lenses, many people with low vision can ... of low vision devices, such as telescopes, magnifiers and ... Iyer is using the three-year, $164,645 SightFirst grant from ...
Breaking Biology News(10 mins):Moose drool inhibits growth of toxic fungus: York U research 2New imaging agent provides better picture of the gut 2UTHealth Dr. Bhavani Iyer awarded low vision grant 2
... who are exposed to manganese from welding fumes, risk developing ... exposure has ceased. This is the finding of a study ... It is estimated that 35,000 people in Sweden work ... one of several workplace activities. Previous research has shown that ...
... new strategies are needed to find and treat individuals ... disease. The prevalence of asymptomatic or minimally symptomatic malaria ... with malaria and these asymptomatic individuals can serve as ... disease transmission has declined. In a new ...
... The National Foundation for Cancer Research announced today that ... awarded the 7th annual Szent-Gyrgyi Prize for Progress in ... the successful development of a new therapeutic approach to ... traditional Chinese medicine with Western medicine, Drs. Wang and ...
Cached Biology News:Increased clumsiness in former welders 2'Test and Treat' model offers new strategy for eliminating malaria 2Chinese scientists Zhen-Yi Wang and Zhu Chen awarded 7th annual Szent-Gyorgyi Prize 2
This is a PYREX replacement Allihn condenser with a 34/45 inner joint on the bottom for the No. CLS3840-S 125mL extractor system. The tubulation O.D. on the condenser is 10mm....
... unique human proteins on a 1x3 ... a cross section of all cellular ... high-quality results. Additional control proteins and ... validity and reproducibility., ,UNIchip protein microarrays ...
... unique human proteins on a 1x3 ... all intracellular proteins (IP) according to ... quadruplicate for high-quality results. Additional control ... guarantee high validity and reproducibility., UNIchip ...
...
Biology Products: